Big news! All of A+ Science operations are now part of CTC Clinical Trial Consultants AB!

We are happy to confirm that the transfer of A+ Science AB’s business into CTC Clinical Trial Consultants AB has been completed as of 1 January 2024, resulting in all operations of A+ Science AB transferred and incorporated successfully into the CTC organization.

CTC is a full-service CRO with the mission to facilitate clinical and translational research by providing our customers with cost-effective advice, conduct and reporting of clinical trials. We perform in-house clinical conduct at our first-in-human (FIH) and Phase I-IV clinical research units in Uppsala, Stockholm, Linköping and Gothenburg. Our clinics work in close collaboration with our inhouse Clinical Operations, Biometrics, Pharmacovigilance and DMPK & Clinical Pharmacology departments to provide a true full-service option to our customers. The acquisition of A+ Science has now expanded CTC’s portfolio of pharmacovigilance services and reinforces other operational activities.

Please find further information of CTCs business and capabilities at our website: https://www.ctc-ab.se/.

Press release with regards to the acquisition of A+ Science+: https://www.ctc-ab.se/ctr-center-for-translational-research-ab-acquires-a-science-ab/

For further information and details about the acquisition, please contact:
Anders Millerhovf, CEO, anders-(d_)-_millerhovf-(_sm3Remove)-_-(_a)-_ctc-ab-(d_)-_se
Eva Fredriksson, CEO at A+ Science AB, eva-(d_)-_fredriksson-(_sm3Remove)-_-(_a)-_ctc-ab-(d_)-_se

For additional information, please refer to Investor Relations section here.